Abstract Background: Treatment of invasive Stenotrophomonas maltophilia infections is
difficult due to this organism's inherent multidrug resistance and increasing resistance to …

Stenotrophomonas maltophilia has emerged as a significant pathogen in compromised
patients, causing infections which are difficult to treat. Clinical isolates from patients in the …

Stenotrophomonas maltophilia is an important emerging pathogen causing a variety of
infections in severely ill patients. This microorganism is inherently resistant to many …

Stenotrophomonas maltophilia is an emerging opportunistic pathogen, classified by the
World Health Organization as one of the leading multidrug-resistant organisms in hospital …

Background Stenotrophomonas maltophilia is intrinsically resistant to several antibiotics,
making it potentially challenging to treat. Studies have demonstrated treatment failures and …

Emergence of Stenotrophomonas maltophilia as a nosocomial pathogen is becoming
increasingly apparent. Pleiotropic resistance characterizes S. maltophilia. Furthermore, a …

Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic
pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia …

Background: Stenotrophomonas maltophilia infection is gaining importance as an important
cause of nosocomial pneumonia due to its characteristic inherent resistance to many broad …

Background: Since the 1980s, Stenotrophomonas maltophilia has emerged as an important
pathogen associated with significant mortality in pneumonia and bacteremia of severely …

Stenotrophomonas (Xanthomonas) maltophilia is a nonfermentative, gram-negative bacillus
that is widely distributed in natural and humanmade environments. In the nonhospital setting …